SKIN CANCER
AITIS is active in both healthcare diagnostics and healthcare prevention. We aim to save lives and improve the health and well-being of our society. Our team provides AI products to detect, measure, inform, alert, raise awareness and provide explainability
Patient Impact
-
Impacts also family and work
-
Emotional distress
-
Reduced mobility
-
Social Isolation
-
Likely home/bed-bound
What makes AITIS different?
Our cutting-edge AI innovation accelerated by the AITIS platform for model creation with explainable AI and client-deployment.
AI Innovation
We have completed 2-year hospital wound clinical trials, are published in the IWJ and starting new predictive clinical trials this year.
Clinical Trials
We provide scalable, efficient, cost-effective AI solutions and can offer volume- and value-based or other pricing to suit our client needs.
Cost-Effective
Our Skin Cancer APP
Developed with Singapore’s National Skin Centre, our Skin Cancer App enables early detection of melanomas and non-melanoma skin cancers (NMSCs). Simply take a photo of a skin lesion or unusual mark and the app uses advanced AI and the ABCD risk score to provide clear, reliable insights. It can identify naevi, seborrheic keratoses, basal and squamous cell carcinomas and melanoma. Available on mobile and desktop, it supports clinicians and patients for timely diagnosis and better outcomes.
Our Collaborations
